You are here : Home > Services > API Manufacturing
Moving towards full-scale API manufacturing

CARBOGEN AMCIS has over 10 years of experience in the supply of APIs for clinical trials and commercial production and is specialized in the multi-step cGMP manufacture of low volume APIs (20 kg to 2000 kg). The goal is to supply our clients with market-ready quantities of APIs including drug mater files and regulatory documentation.

As part of the Dishman Group, CARBOGEN AMCIS offers the option of internal technology transfer to FDA approved large scale production facilities in India.

An efficient technology transfer process is the key for a successful transfer. This has already been proven by the transfer of several complex, multi-step processes under both GMP and nonGMP conditions to Dishman India.

With an established three-stage procedure consisting of 1. initiation; 2. piloting and 3. sign-off, a specialist team with clearly defined responsibilities throughout the transfer process relies on frequent communication between the sites to overcome the possible linguistic and cultural barriers.

Case Studies

16 February 2018
CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland

11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

DCAT week

World ADC Berlin